An official justified the situation due to “high demand for patients” who arrive after the COVID-19 vaccination. He said that there is a 71% supply of medicines.
“Not even ibuprofen They were able to hit my wife, who came in uncomfortable on Tuesday, ”was Freddy N.’s complaint after going to the hospital of the Ecuadorian Social Security Institute (IESS) in Ambato.
Like his, complaints are multiplied among those who come to the consultations at the social security hospital.
Juan Núñez, for example, commented that they told him that there is no tamsulosin that the doctor prescribed for the treatment of his prostate; to come back in mid-January of next year to see “if it has already arrived.”
Fabiola Lema also expressed her discomfort because they could not perform an intervention due to bladder descent, since there are no meshes (surgical) that are needed in these cases. “I had to beg to be echoed, but I don’t have a new date, because it is not known when the supplies and medicines that are missing for the affiliates will arrive ”, he explained.
And there are more cases every day. Carlos Urbina said that, after a consultation he had with the ophthalmologist, he went to pick up the medications that were prescribed, but at the IESS pharmacy they told him that there was no Vitalux dropper and that they did not know when it will arrive, he claimed.
Doubts and concerns regarding government announcement of massive and immediate purchase of drugs for hospitals
Diana Claudio, on the other hand, has to do some exams in the area of Gynecology, but they told him that he has to come back next year to find out when they can be done, since shifts are full until the end of January 2022.
Santiago Apunte, administrative director of the IESS Ambato hospital, acknowledged that you do not have all the medications and that the health home is with 71% supply. Said there is more than 73% of medical supplies and that the last purchases of this 2021 are made, with which it is expected to have 90% of the medicines.
According to Apunte, after the vaccination process against COVID-19, people have approached en masse to the hospital in order to receive care in the different pathologies. That, he claimed, has made the rotation of medicines and supplies develop more quickly, since it was not ready for that demand.
Members and retirees were dissatisfied because they were unable to receive all the medications prescribed for them.
“In this difficult economic situation that we find ourselves, we have to go shopping in private pharmacies, because if we wait for them to have insurance, our health worsens,” some of them said.
They also hope that the offer made by the Government to supply enough medicines and supplies to the hospitals will be fulfilled.
IESS patients hope that the promise of endowment of medicines is not sporadic. Teodoro Maldonado Carbo hospital plans to increase purchasing processes
On Wednesday December 8, Francisco Cepeda, President of the Board of Directors, said, in his appearance before the Health Commission of the National Assembly, which until the end of the year the IESS will have a 80% supply of medicines in their hospitals.
According to Cepeda, two months ago the supply level was 47% and 64% availability, while to date it is 60%.
He indicated that in the Teodoro Maldonado hospital, in Guayaquil, the availability was (at that cut) 60%; in the José Carrasco hospital in Cuenca, 68%; in the IESS Quito Sur hospital, 83%, and in the Los Ceibos hospital, in Guayaquil, 85%, where a purchase has been made by auction for very small amounts.
He assured that there is a centralized problem in the Carlos Andrade Marín hospital, in Quito, where availability was 28%.
The official stated that modifications to decree 1033 to improve medicine purchases from 2022.
And he set a date for the arrival of some medicines for certain diseases, such as muscular dystrophy: December 18. (I)
Paul is a talented author and journalist with a passion for entertainment and general news. He currently works as a writer at the 247 News Agency, where he has established herself as a respected voice in the industry.
